MINERVA SURGICAL, INC.

Analyst Reco. Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 01:25:19 2025-06-13 pm EDT			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	+9,900.00%

2024	From Mammograms to Molecules: Hologic's Quest in Women's Health Tech
2024	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	CI

Analyst Reco.

Piper Sandler Adjusts Minerva Surgical's Price Target to $1 From $5, Keeps Overweight Rating	23-05-03	MT
JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight	22-08-10	MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overweight Rating	22-08-10	MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $6 From $12, Reiterates Overweight Rating	22-05-12	MT
UBS Adjusts Minerva Surgical Price Target to $14 From $15, Maintains Buy Rating	22-03-09	MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $12 From $17, Reiterates Overweight Rating	22-03-09	MT
SVB Leerink Adjusts Price Target on Minerva Surgical to $12 From $17, Maintains Outperform Rating	21-12-03	MT
SVB Leerink Starts Minerva Surgical at Outperform With $17 Price Target	21-11-16	MT
UBS Starts Minerva Surgical at Buy With $15 Price Target	21-11-16	MT
JPMorgan Starts Minerva Surgical at Overweight With $14 Price Target	21-11-16	MT
Piper Sandler Starts Minerva Surgical at Overweight With $17 Price Target	21-11-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies